chartexchange

LUNG
Pulmonx Corporation Common Stock
stockNASDAQ

Market OpenNov 19, 2026 2:49:45 PM EST
2.75USD+2.230%(+0.06)469,663
Pre-marketNov 19, 2026 9:28:30 AM EST
2.72USD+1.115%(+0.03)
2.7500Bid2.7600Ask0.0100Spread
Loading…
Loading…
119.76M
Healthcare
Medical Devices
HQ
Redwood City, CA, USA
Previous Close
$2.69
Beta
1.96
52-Week High
$3.25 2026-10-29
52-Week Low
$1.13 2026-03-30
SMA 50
$2.18
SMA 200
$1.72
Avg. Vol 10D
716,957
Avg. Vol 30D
998,812
Avg. Vol 90D
662,550
Relative Vol
0.47
38.21M
2.2900%
1,700,000
6,244
LUNG Profile

pulmonx is focused on developing life-changing technologies that improve the lives of patients suffering from lung disease. the company's first commercial products address emphysema, a form of copd (chronic obstructive pulmonary disease) and the largest unmet medical need in pulmonology. with emphysema, breathing becomes increasingly more difficult as the disease progresses. today in the u.s., advanced emphysema patients have no available alternatives but lung volume reduction surgery, which is associated with high morbidity and mortality, and lung transplantation, which is limited by the availability of donor organs. pulmonx has developed the zephyr endobronchial valve (ebv) therapy, a non-surgical, investigational approach to treating emphysema. the minimally invasive zephyr valve is a tiny, one-way valve designed to reduce the volume of the diseased regions of the lung by blocking airflow, in order to improve breathing and increase activity levels. no surgery is involved in the simp

LUNG Performance
PeriodPriceDateChangeBeta
1W3.002026-11-12-8.33%-0.645
1M1.752026-10-19+57.14%2.995
3M2.312026-08-19+19.05%2.148
6M1.342026-05-19+105.22%2.492
1Y1.382025-11-19+99.28%1.961
2Y6.002024-11-19-54.17%—
5Y34.662021-11-19-92.07%1.428
LUNG Stock Summary

Pulmonx Corporation Common Stock (NASDAQ:LUNG) stock price today is $2.75, and today's volume is 468,991. LUNG is up 2.230% today. The 30 day average volume is 998,812. LUNG market cap is $119.76M with 43.55M shares outstanding.